- 13
February 2013. Druker, B. J.; Talpaz, M.; Resta, D. J.; Peng, B.;
Buchdunger, E.; Ford, J. M.; Lydon, N. B.; Kantarjian, H.; Capdeville, R.; Ohno-Jones...
- doi:10.1038/379645a0. PMID 8628398. S2CID 2528506.
Druker BJ,
Tamura S,
Buchdunger E, Ohno S,
Segal GM,
Fanning S,
Zimmermann J,
Lydon NB (1996). "Effects...
- PMC 1480579. PMID 15775848.
Retrieved on
October 29, 2008. Wood JM, Bold G,
Buchdunger E, et al. (April 2000). "PTK787/ZK 222584, a
novel and
potent inhibitor...
- by the
British biochemist Nicholas Lydon and that
included Elisabeth Buchdunger and Jürg Zimmermann, and its use to
treat CML was
driven by oncologist...
- Chemistry). Weinheim: Wiley-VCH. ISBN 978-3-527-29343-8.
Capdeville R,
Buchdunger E,
Zimmermann J,
Matter A (July 2002). "Glivec (STI571, imatinib), a rationally...
- sarcoma". Natl
Cancer Inst
Monogr (56): 201–6. PMID 6975438.
Corbin AS,
Buchdunger E,
Pascal F,
Druker BJ (August 2002). "Analysis of the
structural basis...
- 1742-4658.2009.07449.x. PMID 19922468.
Druker BJ,
Talpaz M,
Resta DJ, Peng B,
Buchdunger E, Ford JM, et al. (April 2001). "Efficacy and
safety of a
specific inhibitor...
- OHSU". www.ohsu.edu.
Retrieved 2023-10-13. Druker, B. J.; Tamura, S.;
Buchdunger, E.; Ohno, S.; Segal, G. M.; Fanning, S.; Zimmermann, J.; Lydon, N. B...
-
overcome resistance". Hematology: 461-476. Manley, P.W., Cowan-Jacob, S. W.,
Buchdunger, E., Fabbro, D., Fendrich, G., Furet, P., Meyer, T. and Zimmermann, J...
- Wilkins. pp. 88–. ISBN 978-1-4511-4870-1. Warshamana-Greene GS, Litz J,
Buchdunger E, García-Echeverría C,
Hofmann F,
Krystal GW (February 2005). "The insulin-like...
